Porton Pharma Solutions Ltd.’s Post

Porton Pharma Solutions Ltd. & Porton J-STAR Research, Inc. is a premier #CDMO. We are thrilled to announce our advancements in enhancing #flowability, #compressibility, and #stability through Drug Substance-Drug Product (DS-DP) Co-processing. Increasingly, Co-processing has been investigated as a viable and less expensive alternative to Spray Drying. The Enabling Technologies Consortium (ETC®) has awarded J-STAR a two-year contract to collaborate on the "Co-processing Platform Technology" project, which Dr. San Kiang will lead. Endorsed by the Journal Of Pharmaceutical Sciences, co-processed APIs have become an increasingly viable and practical approach to meet the challenges of the increasing complexity of today’s drugs in development. Co-processed #API contains the API in addition to one or more non-covalently bonded, nonactive components that do not exist in, or alter, the underlying API chemical structure, but with co-processing the results can in many cases allow difficult-to-handle, unstable, and poorly soluble active ingredients to be manufactured into robust drug products using simplified operations including direct continuous compression. Contact Porton J-Star at business@portonusa.com to connect with our team to learn how co-processing might be the right #enabling #technology tool to move your #molecule forward into the #clinic and one step closer to #commercialization. Contact our team here: https://lnkd.in/eacJ7ebb Hope your day is packed with positivity. #follow us here https://lnkd.in/d64pQsdB #drugproduct #drugsubstance #development #GMP #clinical #formulation #solidstate #crystallization #processdevelopment #particleengineering #coprocessing #HPAPI #capabilities #synthesis #cmc #cdmo #api #tides #smallmolecule #customerfocus #adc

Porton Pharma Solutions Ltd. & Porton J-STAR Research, Inc. is a premier #CDMO. We are thrilled to announce our advancements in enhancing #flowability, #compressibility, and #stability through Drug Substance-Drug Product (DS-DP) Co-processing. Increasingly, Co-processing has been investigated as a viable and less expensive alternative to Spray Drying. The  Enabling Technologies Consortium (ETC®) has awarded J-STAR a two-year contract to collaborate on the "Co-processing Platform Technology" project, which Dr. San Kiang will lead. Endorsed by the Journal Of Pharmaceutical Sciences, co-processed APIs have become an increasingly viable and practical approach to meet the challenges of the increasing complexity of today’s drugs in development. Co-processed #API contains the API in addition to one or more non-covalently bonded, nonactive components that do not exist in, or alter, the underlying API chemical structure, but with co-processing the results can in many cases allow difficult-to-handle, unstable, and poorly soluble active ingredients to be manufactured into robust drug products using simplified operations including direct continuous compression. Contact Porton J-Star at business@portonusa.com to connect with our team to learn how co-processing might be the right #enabling #technology tool to move your #molecule forward into the #clinic and one step closer to #commercialization. Hope your day is packed with positivity. #Contact us here! https://lnkd.in/e7zqdNqS #follow us here https://lnkd.in/d64pQsdB #drugproduct #drugsubstance #development #GMP #clinical #formulation #solidstate #crystallization #processdevelopment #particleengineering #coprocessing #HPAPI #capabilities #synthesis #cmc #cdmo #api #tides #smallmolecule #customerfocus #adc

🌟 Novel Approaches & Techniques for Solubility Enhancement of Poorly Water-Soluble Drugs 🌟 Poor solubility is a barrier for 90% of new drugs. This course dives into advanced solubilization strategies like amorphous solid dispersions, extrusion, and spray drying to boost drug bioavailability and development success. 👩🔬 What You’ll Learn: ✅ Solubility theory & enhanced drug forms ✅ Pre-formulation techniques ✅ Cutting-edge solubilization technologies ✅ Regulatory considerations 👨🏫 Your Experts: Prof. Dennis Douroumis & Steven Ross, PhD 💡 Gain actionable insights for applying solubility enhancement in pharmaceutical manufacturing. Ensure your molecules achieve optimal bioavailability! 👉 Join us today! https://lnkd.in/ehF7vEkJ #PharmaceuticalInnovation #DrugDevelopment #SolubilityEnhancement #Pharma

🌟 Novel Approaches & Techniques for Solubility Enhancement of Poorly Water-Soluble Drugs 🌟 Poor solubility is a barrier for 90% of new drugs. This course dives into advanced solubilization strategies like amorphous solid dispersions, extrusion, and spray drying to boost drug bioavailability and development success. 👩🔬 What You’ll Learn: ✅ Solubility theory & enhanced drug forms ✅ Pre-formulation techniques ✅ Cutting-edge solubilization technologies ✅ Regulatory considerations 👨🏫 Your Experts: Prof. Dennis Douroumis & Steven Ross, PhD 💡 Gain actionable insights for applying solubility enhancement in pharmaceutical manufacturing. Ensure your molecules achieve optimal bioavailability! 👉 Join us today! https://lnkd.in/d34DzZA3 #PharmaceuticalInnovation #DrugDevelopment #SolubilityEnhancement #Pharma

💡What makes a formulation truly successful? ❗Formulation science is more than mixing ingredients❗ It’s about understanding their roles, mechanisms, and interactions to create a product that truly delivers. Compatibility between compounds is the cornerstone of a successful formulation. 💊 Sometimes, advances in excipient science can even rejuvenate established drugs, giving them a second life in the market. Innovation in formulation is a win-win for both patients and the pharmaceutical industry. The Medicine Maker published this HOT TOPIC article: https://lnkd.in/dCSe6dAB Let’s keep pushing the boundaries of innovation together with MEDSENIC team : Carole Nicco, Francois Rieger, véronique POMI, Alexia Rieger, Dominique Rongvaux - Gaïda #ATO #arsenic #innovation #autoimmunity #DrugDevelopment #ScienceInnovation #cGvHD #formulation

Porton Pharma Solutions Ltd. & Porton J-STAR Research, Inc. is a premier CDMO (Contract Development and Manufacturing Organization). We are thrilled to announce our advancements in enhancing #flowability, compressibility, and stability through Drug Substance-Drug Product (DS-DP) Co-processing. Increasingly, Co-processing has been investigated as a viable and less expensive alternative to Spray Drying. The Enabling Technologies Consortium (ETC®) has awarded J-STAR a two-year contract to collaborate on the "Co-processing Platform Technology" project, which Dr. San Kiang will lead.   Endorsed by the Journal Of Pharmaceutical Sciences, co-processed APIs have become an increasingly viable and practical approach to meet the challenges of the increasing complexity of today’s drugs in development. Co-processed API contains the API in addition to one or more non-covalently bonded, nonactive components that do not exist in, or alter, the underlying API chemical structure, but with co-processing the results can in many cases allow difficult-to-handle, unstable, and poorly soluble active ingredients to be manufactured into robust drug products using simplified operations including direct continuous compression.   Contact Porton J-Star at business@portonusa.com to connect with our team to learn how co-processing might be the right enabling technology tool to move your #molecule forward into the clinic and one step closer to commercialization. Hope your day is packed with positivity. #follow us here https://lnkd.in/d64pQsdB #health #healthcare #pharmaceutical #science #medicine #coprocessing

🌟 Novel Approaches & Techniques for Solubility Enhancement of Poorly Water-Soluble Drugs 🌟 Poor solubility is a barrier for 90% of new drugs. This course dives into advanced solubilization strategies like amorphous solid dispersions, extrusion, and spray drying to boost drug bioavailability and development success. 👩🔬 What You’ll Learn: ✅ Solubility theory & enhanced drug forms ✅ Pre-formulation techniques ✅ Cutting-edge solubilization technologies ✅ Regulatory considerations 👨🏫 Your Experts: Prof. Dennis Douroumis & Steven Ross 💡 Gain actionable insights for applying solubility enhancement in pharmaceutical manufacturing. Ensure your molecules achieve optimal bioavailability! 👉 Join us today! https://lnkd.in/dZhdw_-K #PharmaceuticalInnovation #DrugDevelopment #SolubilityEnhancement #Pharma

Porton Pharma Solutions Ltd. & Porton J-STAR Research, Inc. is a premier CDMO (Contract Development and Manufacturing Organization). We are thrilled to announce our advancements in enhancing #flowability, compressibility, and stability through Drug Substance-Drug Product (DS-DP) Co-processing. Increasingly, Co-processing has been investigated as a viable and less expensive alternative to Spray Drying. The Enabling Technologies Consortium (ETC®) has awarded J-STAR a two-year contract to collaborate on the "Co-processing Platform Technology" project, which Dr. San Kiang will lead.   Endorsed by the Journal Of Pharmaceutical Sciences, co-processed APIs have become an increasingly viable and practical approach to meet the challenges of the increasing complexity of today’s drugs in development. Co-processed API contains the API in addition to one or more non-covalently bonded, nonactive components that do not exist in, or alter, the underlying API chemical structure, but with co-processing the results can in many cases allow difficult-to-handle, unstable, and poorly soluble active ingredients to be manufactured into robust drug products using simplified operations including direct continuous compression.   Contact Porton J-Star at business@portonusa.com to connect with our team to learn how co-processing might be the right enabling technology tool to move your #molecule forward into the clinic and one step closer to commercialization. Hope your day is packed with positivity. #follow us here https://lnkd.in/d64pQsdB #health #healthcare #pharmaceutical #science #medicine #coprocessing

🌟 Novel Approaches & Techniques for Solubility Enhancement of Poorly Water-Soluble Drugs 🌟 Poor solubility is a barrier for 90% of new drugs. This course dives into advanced solubilization strategies like amorphous solid dispersions, extrusion, and spray drying to boost drug bioavailability and development success. 👩🔬 What You’ll Learn: ✅ Solubility theory & enhanced drug forms ✅ Pre-formulation techniques ✅ Cutting-edge solubilization technologies ✅ Regulatory considerations 👨🏫 Your Experts: Prof. Dennis Douroumis & Steven Ross 💡 Gain actionable insights for applying solubility enhancement in pharmaceutical manufacturing. Ensure your molecules achieve optimal bioavailability! 👉 Join us today! https://lnkd.in/ewehsP4k #PharmaceuticalInnovation #DrugDevelopment #SolubilityEnhancement #Pharma

What if embracing sustainability didn’t add any extra costs to your business?🌱 At Peli, we believe sustainability and scalability can go hand-in-hand. By focusing on scalable solutions, we help you promote growth within your existing operational footprint. Together, we can redefine what's possible for your business and the planet. 🌍